Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0000711377-13-000047)

Filing Details

Accession Number:: 0000711377-13-000047
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2013-10-11 17:34:43
Reporting Period:: 2013-10-09

Filing Date:: 2013-10-11
Accepted Time:: 2013-10-11 17:34:43
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
711377	Neogen Corp	NEOG	In Vitro & In Vivo Diagnostic Substances (2835)	382367843

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1189021	Edward Bradley		Vice President	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2013-10-09	2,880	$19.55	124,567	No	4	M	Direct
Common Stock	Disposition	2013-10-09	2,880	$61.03	121,687	No	4	S	Direct
Common Stock	Acquisiton	2013-10-10	6,500	$19.55	128,187	No	4	M	Direct
Common Stock	Disposition	2013-10-10	6,500	$61.03	121,687	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Common Stock (Right to Buy)	Disposition	2013-10-09	2,880	$0.00	2,880	$19.55
Common Stock	Common Stock (Right to Buy)	Disposition	2013-10-10	6,500	$0.00	6,500	$19.55

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
125,339		2014-08-24	No	4	M	Direct
118,839		2014-08-24	No	4	M	Direct

Footnotes

Options were granted on 8/24/2009, vest equally each year over five years on the anniversary date of the grant, and expire on 8/24/2014